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regulate mitochondrial respiration through cGMP-independent ways.
NO exhibits two main effects on the respiratory chain: the inhibition
of cytochrome oxidase and of electron transfer at complex III. It is
known that the inhibition of complex IV occurs by a competition
between NO and O2 for the reduced CuB/heme a3 center of the
enzyme. However, little is known about how NO interacts with the
NO-reactive component of the ubiquinone-cytochrome b area [1]. The
aim of this work was to study the NO inhibitory effect on electron
transfer between cyt. b and cyt. c, using beef heart inside-out particles
(ETPH-Mg2+), with emphasis on the biochemical characteristics of
this inhibition. S-nitrosoglutathione (GSNO; 0–500 μM) was used as
NO donor. Succinate-cytochrome c reductase activity (222±4 nmol/
min.mg protein) was inhibited (51%) by 500 μM GSNO. This activity
was also reduced (36%) when ETPH-Mg2+ had been incubated in the
presence of l-arginine and mtNOS cofactors (Ca2+ and NADPH),
suggesting that this inhibitory effect is caused by mtNOS-produced
NO. GSNO (500 μM) reduced cyt. b562 within mitochondrial mem-
branes by 70%, similarly to the antimycin effect. The effective [NO]
was assessed using a NO-sensitive electrode: 500 μM GSNO releases
240 nM NO to the reaction medium when the assay is followed
during 2 min. NO produced a hyperbolic increase in O2− and H2O2
production rates with a maximal effect at 500 μM GSNO (1.3±
0.1 nmol O2−/min.mg protein; 0.64±0.05 nmol H2O2/min.mg pro-
tein). The O2−/H2O2 ratio was 2.0 in accordance to the stoichiometry of
the O2− dismutation reaction. EPR spectrum conﬁrmed that the
reactions of duroquinol with NO produces a stable semiquinone,
with a signal centered at g~2.03. ETPH-Mg2+ incubated in the
presence of succinate for 1 min showed an EPR signal at g~1.99,
which was increased by GSNO or antimycin. When ETPH-Mg2+ was
incubated in the presence of GSNO for 5 min EPR spectra showed an
additional signal at g~2.02, suggesting that two ubiquinol pools are
partially oxidized by NO. The interaction of NO with complex III leads
to electron transfer inhibition in an [O2] independent manner, with a
[UQH.]ss enhancement, which in turn generates, an increase in O2− and
H2O2 production rates.
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The bc1 complex is central to mitochondrial bioenergetics and the
target of antimicrobial agents used to control human and plant
pathogens (for instance anti-malaria and fungicides). Most of these
drugs bind to Qo pocket that is provided by the mitochondrially-
encoded cytochrome b, the main subunit of the complex. Comparison
of the cytochrome b sequences shows that the Qo domain is well
conserved between organisms. There are however variations that
could explain the differential sensitivity towards inhibitors, which is
required for the development of therapeutic drugs.
In this work, we are studying two compounds with anti-malaria
activity: atovaquone, a hydroxynaphthoquinone, used in medicine to
treat Plasmodium falciparum malaria, and other infections and that
targets the Qo site; and RQC06, a quinolone compound shown to have
a potent inhibitory activity against the plasmodial bc1 complex [1].
The yeast (Saccharomyces cerevisaie) and P. falciparum bc1 complexes
are highly sensitive towards atovaquone, whereas the mammalian
enzyme, as expected for a therapeutic molecule, is 20–25 fold less
susceptible. RCQ06 is potentially an interesting drug since the
mammalian bc1 complex is also 20–30 fold less sensitive than the
plasmodial enzyme. By contrast, the yeast bc1 complex is naturally
highly resistant to RCQ06.
In order to investigate the determinants of resistance and
sensitivity towards these two drugs, we used the yeast bc1 complex
as model. We constructed and analysed a series of yeast mutants
harbouring variants of the Qo site where yeast residues have been
replaced by P. falciparum or human equivalents. We showed that
residue 275 plays a central role in the differential sensitivity and that
other variants in the Qo site modulate the impact of the mutation
introduced in position 275. By modifying the yeast enzyme, we
are creating useful tools for the discovery and the analyse of new
drugs with potential anti-malaria activity and for the study of the
development of resistance mutations.
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The respiratory chains of anaerobic organisms are usually highly
branched, reﬂecting their ability to use an array of different electron
donors and acceptors. Bacteria often contain new examples of
membrane complexes whose architecture has a modular character,
with different arrangements of modules giving rise to different
proteins and physiological functions.
Here we describe a new respiratory complex from the sulfate
reducing bacterium Desulfovibrio vulgaris Hildenborough, named
Quinone-reductase complex (Qrc) [1]. It is composed of four
subunits, QrcABCD, including a hexaheme cytochrome c (QrcA), a
large protein of the molybdopterin oxidoreductase family, but
which does not bind molybdenum (QrcB), a periplasmic iron–sulfur
protein (QrcC) and an integral membrane protein of the NrfD
family (QrcD). The Qrc complex is the ﬁrst representative of a new
family of redox complexes, but the QrcBCD subunits are closely
related with members of the complex iron–sulfur molybdoenzyme
(CISM) family (also known as DMSO reductase family) [2]. Qrc is also
closely related to the alternative complex III, but has the reverse
catalytic activity, acting as a Type I cytochrome c3: menaquinone
oxidoreductase.
The Qrc complex contains six c-type low-spin hemes, one [3Fe–
4S]1+/0 cluster and three [4Fe4S]2+/1+ clusters, and their redox
potentials were determined [3]. Binding of a menaquinone analog
affects the EPR spectrum of the [3Fe–4S]+1/0 cluster, indicating
the presence of a quinone-binding site close to the periplasmic
subunits.
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